Notice of Intent to Sole Source Award for development of a Sufentanil NanoTab Dispenser.

The U.S. Army Medical Research Acquisition Activity (USAMRAA) proposes to award to AcelRx Pharmaceuticals, Inc., Redwood City, CA, on a sole source basis, for the purchase of the required supplies / services for the research and development (R&D) of a Sufentanil NanoTab dispenser that will address combat medic and trauma surgery needs that are not met by existing commercial systems. It will include features / capabilities specifically designed for a multi-dose NanoTab opioid dispenser for the medic/patient. The ultimate objective is to develop and validate a concept and design for a sublingual NanoTab dispenser system. The NanoTab is only produced by AcelRx Pharmaceuticals, Inc., and thus this procurement shall be under other than full and open competition procedures in accordance with FAR 6.302. All responsible sources may submit a capability statement, proposal, or quotation which shall be considered by USAMRAA. This announcement will be publicized for thirty (30) days, after which a redacted sole source justification and approval document will be posted and award will be made to AcelRx Pharmaceuticals, Inc. The Point of Contact (POC) for this action is: chasen.deener@amedd.army.mil.